Stockreport

Gritstone bio Announces Interim Phase 2 Data for GRANITE Individualized Neoantigen Targeting Immunotherapy in Frontline Metastatic Microsatellite Stable Colorectal Cancer

Gritstone bio, Inc.  (GRTS) 
Last gritstone bio, inc. earnings: 11/12 09:01 am Check Earnings Report
PDF --Encouraging progression-free survival data in overall population; continued follow-up needed to allow data to mature further, especially in low ctDNA subgroup where ev [Read more]